| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |